Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:36 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 508869 | NSE: APOLLOHOSP

Apollo Hospitals Enterprise Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹5,391.14Overvalued by 26.21%vs CMP ₹7,306.00

P/E (57.8) × ROE (18.4%) × BV (₹632.00) × DY (0.26%)

₹2,364.48Overvalued by 67.64%vs CMP ₹7,306.00
MoS: -209% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹5,999.5923%Over (-17.9%)
Graham NumberEarnings₹1,334.9316%Over (-81.7%)
Earnings PowerEarnings₹32.6911%Over (-99.6%)
DCFCash Flow₹1,715.2414%Over (-76.5%)
Net Asset ValueAssets₹632.457%Over (-91.3%)
EV/EBITDAEnterprise₹2,608.599%Over (-64.3%)
Earnings YieldEarnings₹1,253.207%Over (-82.8%)
ROCE CapitalReturns₹642.497%Over (-91.2%)
Revenue MultipleRevenue₹2,273.765%Over (-68.9%)
Consensus (9 models)₹2,364.48100%Overvalued
Key Drivers: Wide model spread (₹33–₹6,000) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 11.3%

*Investments are subject to market risks

Investment Snapshot

66
Apollo Hospitals Enterprise Ltd scores 66/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health78/100 · Strong
ROCE 16.6% GoodROE 18.4% ExcellentD/E 0.54 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding up 0.80% (6mo) Slight increaseDII holding down 0.79% MF sellingPromoter holding at 28.0% Stable
Earnings Quality50/100 · Moderate
OPM stable around 14% Steady
Quarterly Momentum80/100 · Strong
Revenue (4Q): +14% YoY GrowingProfit (4Q): +41% YoY Strong
Industry Rank60/100 · Moderate
P/E 57.8 vs industry 75.2 In-lineROCE 16.6% vs industry 14.7% AverageROE 18.4% vs industry 13.9% Above peers3Y sales CAGR: 14% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:36 am

Market Cap 1,05,042 Cr.
Current Price 7,306
Intrinsic Value₹2,364.48
High / Low 8,100/6,491
Stock P/E57.8
Book Value 632
Dividend Yield0.26 %
ROCE16.6 %
ROE18.4 %
Face Value 5.00
PEG Ratio5.12

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Apollo Hospitals Enterprise Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Apollo Hospitals Enterprise Ltd 1,05,042 Cr. 7,306 8,100/6,49157.8 6320.26 %16.6 %18.4 % 5.00
Max Healthcare Institute Ltd 93,319 Cr. 959 1,314/93464.0 1030.16 %14.9 %12.7 % 10.0
Fortis Healthcare Ltd 60,019 Cr. 795 1,105/52159.6 1250.13 %12.0 %10.1 % 10.0
Aster DM Healthcare Ltd 35,559 Cr. 688 732/45098.7 87.50.73 %10.7 %8.26 % 10.0
Dr Lal Pathlabs Ltd 22,178 Cr. 1,324 1,771/1,17640.4 1430.91 %28.9 %24.3 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Apollo Hospitals Enterprise Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 4,2514,2644,3024,4184,8474,8514,9445,0865,5895,5275,5925,8426,304
Expenses 3,6993,7803,8143,9094,2194,2374,3034,4104,7744,7654,8224,9905,362
Operating Profit 552484488509628614640675816762770852941
OPM % 13%11%11%12%13%13%13%13%15%14%14%15%15%
Other Income 23352034262937494469725461
Interest 9310095106111113119116118110115108110
Depreciation 155153159167163167190177184185211215218
Profit before tax 327266254270379363368430557536516583675
Tax % 35%39%43%36%34%30%30%27%29%29%20%24%27%
Net Profit 213162146173249254258316396379414441494
EPS in Rs 14.1910.6810.0511.5916.2017.0617.6521.2326.3425.8927.1030.1033.19

Last Updated: January 2, 2026, 11:30 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 7:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 4,3575,1296,1507,2568,2439,61711,24710,56014,66316,61219,05921,79424,215
Expenses 3,6814,3925,4656,5227,4428,5489,6569,42012,47414,54816,66518,76120,687
Operating Profit 6767376847348011,0701,5911,1402,1892,0652,3943,0333,528
OPM % 16%14%11%10%10%11%14%11%15%12%13%14%15%
Other Income 18479260242622210336875123222235
Interest 119118180257295327533449379381449458445
Depreciation 168212264314359396620573601615687758863
Profit before tax 4074553322221713736602211,5781,1441,3802,0392,455
Tax % 25%29%29%41%65%47%34%38%30%22%32%26%
Net Profit 315335235131602004321371,1088449351,5051,866
EPS in Rs 22.7724.4316.9915.888.4416.9632.7010.4673.4256.9762.50100.56125.32
Dividend Payout % 25%24%35%38%59%35%18%29%16%26%26%13%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)6.35%-29.85%-44.26%-54.20%233.33%116.00%-68.29%708.76%-23.83%10.78%60.96%
Change in YoY Net Profit Growth (%)0.00%-36.20%-14.40%-9.94%287.53%-117.33%-184.29%777.05%-732.59%34.61%50.18%

Apollo Hospitals Enterprise Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:14%
3 Years:14%
TTM:14%
Compounded Profit Growth
10 Years:16%
5 Years:34%
3 Years:18%
TTM:52%
Stock Price CAGR
10 Years:20%
5 Years:37%
3 Years:23%
1 Year:14%
Return on Equity
10 Years:11%
5 Years:14%
3 Years:15%
Last Year:18%

Last Updated: September 4, 2025, 11:25 pm

Balance Sheet

Last Updated: December 4, 2025, 12:57 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 70707070707070727272727272
Reserves 2,9073,1023,2623,2443,1823,2643,2704,5315,5516,1266,8648,1409,021
Borrowings 1,3441,9922,8343,1253,4273,6733,5964,1604,0684,3325,3337,8647,987
Other Liabilities 1,0291,2961,1951,6651,9172,1594,3542,6293,5703,8864,4744,5684,870
Total Liabilities 5,3506,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64421,950
Fixed Assets 2,6813,2443,9974,5914,7734,9827,4326,7788,2968,5209,66410,98811,262
CWIP 491533562347712822236234466108739211,026
Investments 3223113524063524624341,3438165749862,4873,008
Other Assets 1,8552,3722,4482,7592,7592,9013,1873,0374,1044,7125,2196,2486,653
Total Assets 5,3506,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64421,950

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 3734705976235379051,2931,2651,6961,3771,9202,136
Cash from Investing Activity + -356-759-888-1,152-405-711-289-880-747-857-1,537-3,381
Cash from Financing Activity + -63392330477-108-215-910-340-792-633-3111,317
Net Cash Flow -4610339-5224-209444158-1137273
Free Cash Flow -222-396-393-46-842337829841,044252785439
CFO/OP 72%77%108%103%83%103%100%108%87%85%100%86%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow675.00736.00682.00731.00798.00-2.00-2.00-3.00-2.00-2.00-3.00-4.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 444336383739334644494851
Inventory Days 475049475146491621171716
Days Payable 555966515556607479828872
Cash Conversion Cycle 36341934332922-12-14-16-23-6
Working Capital Days 232416278-3-8-45-1-19-6
ROCE %12%12%9%8%7%10%14%8%17%14%15%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.34%29.34%28.02%28.02%
FIIs 46.96%47.93%46.15%46.25%45.63%43.92%45.37%45.27%42.74%43.49%44.20%43.54%
DIIs 17.76%17.02%18.59%18.87%19.55%21.13%19.94%19.97%22.29%21.34%21.12%21.50%
Government 0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%
Public 5.72%5.49%5.68%5.32%5.26%5.38%5.12%5.21%5.41%5.61%6.43%6.71%
No. of Shareholders 1,31,9371,20,0301,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,648

Shareholding Pattern Chart

No. of Shareholders

Apollo Hospitals Enterprise Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis Large Cap Fund 982,831 2.11 684.1919,5262026-01-25 12:22:336.88%
Mirae Asset Large Cap Fund 836,175 1.44 582.02804,0812026-02-23 01:16:543.99%
Mirae Asset Large & Midcap Fund 684,370 1.13 476.36538,5972026-01-25 06:22:2927.07%
Axis Focused Fund 668,123 4.09 465.05N/AN/AN/A
HDFC Flexi Cap Fund 650,000 0.46 452.43N/AN/AN/A
Nippon India Pharma Fund 648,795 5.73 451.59648,7952025-04-22 17:25:420%
Mirae Asset ELSS Tax Saver Fund 640,797 1.71 446.03558,9512026-01-25 15:15:0414.64%
Franklin India Flexi Cap Fund 591,846 2.11 411.95N/AN/AN/A
Invesco India Contra Fund 569,764 1.99 396.58696,4692026-02-23 01:49:47-18.19%
Aditya Birla Sun Life Large Cap Fund 465,347 1.07 323.9N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 100.5662.5056.9773.4210.74
Diluted EPS (Rs.) 100.5662.5056.9773.4210.74
Cash EPS (Rs.) 155.05111.54104.51118.3449.31
Book Value[Excl.RevalReserv]/Share (Rs.) 571.09509.07454.19408.74333.96
Book Value[Incl.RevalReserv]/Share (Rs.) 571.09509.07454.19408.74333.96
Revenue From Operations / Share (Rs.) 1515.581325.401155.251019.65734.35
PBDIT / Share (Rs.) 224.07173.64148.81157.3982.22
PBIT / Share (Rs.) 171.39125.87106.02115.6242.37
PBT / Share (Rs.) 139.5194.7579.53109.7415.35
Net Profit / Share (Rs.) 102.3763.7761.7276.579.46
NP After MI And SOA / Share (Rs.) 100.5562.4956.9673.4110.46
PBDIT Margin (%) 14.7813.1012.8815.4311.19
PBIT Margin (%) 11.309.499.1711.335.76
PBT Margin (%) 9.207.146.8810.762.08
Net Profit Margin (%) 6.754.815.347.501.28
NP After MI And SOA Margin (%) 6.634.714.937.191.42
Return on Networth / Equity (%) 17.6012.9513.2118.773.26
Return on Capital Employeed (%) 15.3214.9713.7315.386.49
Return On Assets (%) 6.995.365.678.001.31
Long Term Debt / Equity (X) 0.530.320.310.430.53
Total Debt / Equity (X) 0.640.450.430.460.54
Asset Turnover Ratio (%) 1.171.220.540.550.86
Current Ratio (X) 1.531.131.301.731.79
Quick Ratio (X) 1.431.031.191.551.66
Inventory Turnover Ratio (X) 46.340.000.000.000.00
Dividend Payout Ratio (NP) (%) 18.8924.0031.154.1325.46
Dividend Payout Ratio (CP) (%) 12.3913.6017.792.635.29
Earning Retention Ratio (%) 81.1176.0068.8595.8774.54
Cash Earning Retention Ratio (%) 87.6186.4082.2197.3794.71
Interest Coverage Ratio (X) 7.035.565.625.982.63
Interest Coverage Ratio (Post Tax) (X) 4.213.043.333.131.17
Enterprise Value (Cr.) 99584.2793953.5264237.5766797.8843713.80
EV / Net Operating Revenue (X) 4.574.933.874.564.14
EV / EBITDA (X) 30.9137.6330.0229.5136.97
MarketCap / Net Operating Revenue (X) 4.374.793.734.433.95
Retention Ratios (%) 81.1075.9968.8495.8674.53
Price / BV (X) 11.6013.1710.0011.559.07
Price / Net Operating Revenue (X) 4.374.793.734.433.95
EarningsYield 0.010.010.010.010.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 8202.10 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesNo.19, Bishop Gardens, Chennai (Madras) Tamil Nadu 600028Contact not found
Management
NamePosition Held
Dr. Prathap C ReddyFounder & Chairman
Mrs. Preetha ReddyExecutive Vice Chairperson
Mrs. Suneeta ReddyManaging Director
Mrs. Sangita ReddyJoint Managing Director
Mrs. Shobana KamineniNon Exe.Non Ind.Director
Mrs. V Kavitha DuttIndependent Director
Dr. Murali DoraiswamyIndependent Director
Mrs. Rama BijapurkarIndependent Director
Dr. Som MittalIndependent Director
Mr. M B N RaoLead Independent Director

FAQ

What is the intrinsic value of Apollo Hospitals Enterprise Ltd and is it undervalued?

As of 19 April 2026, Apollo Hospitals Enterprise Ltd's intrinsic value is ₹2364.48, which is 67.64% lower than the current market price of ₹7,306.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (18.4 %), book value (₹632), dividend yield (0.26 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd is trading at ₹7,306.00 as of 19 April 2026, with a FY2026-2027 high of ₹8,100 and low of ₹6,491. The stock is currently in the middle of its 52-week range. Market cap stands at ₹1,05,042 Cr..

How does Apollo Hospitals Enterprise Ltd's P/E ratio compare to its industry?

Apollo Hospitals Enterprise Ltd has a P/E ratio of 57.8, which is below the industry average of 75.17. This is broadly in line with or below the industry average.

Is Apollo Hospitals Enterprise Ltd financially healthy?

Key indicators for Apollo Hospitals Enterprise Ltd: ROCE of 16.6 % indicates efficient capital utilization; ROE of 18.4 % shows strong shareholder returns. Dividend yield is 0.26 %.

Is Apollo Hospitals Enterprise Ltd profitable and how is the profit trend?

Apollo Hospitals Enterprise Ltd reported a net profit of ₹1,505 Cr in Mar 2025 on revenue of ₹21,794 Cr. Compared to ₹1,108 Cr in Mar 2022, the net profit shows an improving trend.

Does Apollo Hospitals Enterprise Ltd pay dividends?

Apollo Hospitals Enterprise Ltd has a dividend yield of 0.26 % at the current price of ₹7,306.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Apollo Hospitals Enterprise Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports